Biohaven Ltd.BHVNNYSE
Loading
Book Value/Share Growth AcceleratingAccelerating
Percentile Rank94
3Y CAGR+14.0%
5Y CAGR+17.9%
Year-over-Year Change
Year-over-year book value per share growth
3Y CAGR
+14.0%/yr
Quarterly compound
5Y CAGR
+17.9%/yr
Recent deceleration
Percentile
P94
Near historical high
vs 5Y Ago
2.3x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 367.16% |
| Q3 2025 | -112.34% |
| Q2 2025 | -48.35% |
| Q1 2025 | -39.25% |
| Q4 2024 | 25.13% |
| Q3 2024 | -23.42% |
| Q2 2024 | 18.36% |
| Q1 2024 | -31.01% |
| Q4 2023 | 26.14% |
| Q3 2023 | -25.19% |
| Q2 2023 | -18.05% |
| Q1 2023 | -21.79% |
| Q4 2022 | 247.75% |
| Q3 2022 | 264.80% |
| Q2 2022 | 105.36% |
| Q1 2022 | -592.56% |
| Q4 2021 | 119.59% |
| Q3 2021 | -121.53% |
| Q2 2021 | -35.39% |
| Q1 2021 | -384.13% |
| Q4 2020 | 161.43% |
| Q3 2020 | -326.90% |
| Q2 2020 | -127.93% |
| Q1 2020 | 1627.41% |
| Q4 2019 | -106.20% |
| Q3 2019 | -44.67% |
| Q2 2019 | 88.31% |
| Q1 2019 | 0.00% |
| Q4 2018 | -100.00% |
| Q3 2018 | -46.28% |
| Q2 2018 | 4.13% |
| Q1 2018 | 0.00% |
| Q4 2017 | -100.00% |
| Q3 2017 | -41.31% |
| Q2 2017 | 376.20% |
| Q1 2017 | 0.00% |